A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects | Journal of Medicinal Chemistry
Nature's first “atypical opioids”: Kratom and mitragynines - Raffa - 2018 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium? | Bentham Science
Lateral Flow Assessment and Unanticipated Toxicity of Kratom
Opioid-based plant might not be best solution for those seeking to curb habitual alcohol use - Purdue University News
Frontiers | The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
Kratom - Proteopedia, life in 3D
Is Kratom the New 'Legal High' on the Block?: The Case of an Emerging Opioid Receptor Agonist with Substance Abuse Potential. | Semantic Scholar
Frontiers | Comparative Toxicity Assessment of Kratom Decoction, Mitragynine and Speciociliatine Versus Morphine on Zebrafish (Danio rerio) Embryos
Kratom - Proteopedia, life in 3D
Molecular docking evaluation of the alkaloids at the mu opioid... | Download Scientific Diagram
Molecules | Free Full-Text | A Critical Review of the Neuropharmacological Effects of Kratom: An Insight from the Functional Array of Identified Natural Compounds
κ-opioid receptor - Wikipedia
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions | Scientific Reports
The secrets of kratom - Interview with Jay McLaughlin - Blossom
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators | Journal of the American Chemical Society
Scientists Just Solved a Major Piece of the Opioid Puzzle | WIRED
G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder - Gutridge - 2020 - British Journal of Pharmacology - Wiley Online Library
Molecules | Free Full-Text | Biased Opioid Ligands
Site selective C–H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy | Nature Communications
Kratom (Mitragyna speciosa) drug profile | www.emcdda.europa.eu
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site | eLife
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency's scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse | FDA
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions | Scientific Reports
